RiverVest Venture Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Curzion Pharmaceuticals IncMar 2019acquired by Horizon Therapeutics
Acquired by Horizon Therapeutics in 2020.
BiotechSan Diego, US
Mike Grey(Executive Officer, Director)Susan Dube(Executive Officer)
BoardKyle Rasbach(Director)Johan Kordel(Director)Ed Mathers(Director)in
Board seatNiall O'Donnell· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.